Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hip block could cut opioid use after surgery

NCT ID NCT06369948

Symptom relief Sponsor: Fayoum University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new type of nerve block called the PENG block in 60 adults having hip surgery. The goal was to see if it reduces pain and the need for opioid painkillers after the operation. The block targets nerves around the hip joint while avoiding leg muscle weakness.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Pericapsular Nerve Group (PENG) block
What this could lead to
If it works, this could offer a better way to manage pain after hip surgery with less opioid use and fewer side effects like leg weakness.
What could go wrong
This is a small, completed study (60 people) comparing a procedure to standard care. Results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Mar 2024

Finished

Sep 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * \- patients 18 years old or older with ASA physical status 1-3, patients who had no contraindications for spinal anesthesia, and patients undergoing elective surgery. Exclusion Criteria: * Patients with ASA physical status 4 or above. * Pre-existing anatomical or neurological deficits in the lower extremity. * Intolerance or allergy to local anesthetics. * Narcotic dependency. * Coagulopathy or using antiplatelet or anticoagulant medications. * Neuromuscular diseases. * Psychiatric illnesses (schizophrenia, bipolar, uncontrolled anxiety or depression). * Systemic infections or infections at site of injection.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip fracture are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

agnosia hip fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hip hemiarthroplasty

Contacts and locations

Locations

  • Fayoum University Hospital

    El Fayoum Qesm, Fayoum Governorate, 63514, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.